Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis
NCT04989296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2021-08-04
Summary
This study is the first to quantify the level of NF-kB translocation in lymphocyte populations in children and adolescents with psoriasis of varying severity.
Conditions
- Psoriasis Vulgaris
Interventions
- DIAGNOSTIC_TEST
-
Peripheral blood samples were obtained following the standard procedures.
Taking 4 ml of peripheral blood from patients on an empty stomach.
Sponsors & Collaborators
-
National Medical Research Center for Children's Health, Russian Federation
lead OTHER_GOV
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2019-11-20
- Completion
- 2020-01-15
Countries
- Russia
Study Locations
More Related Trials
-
The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis
NCT03526705 ·Status: UNKNOWN ·Phase: NA
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914 ·Status: COMPLETED
-
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
NCT05254249 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
TSO for Plaque Psoriasis
NCT02011269 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
NCT00879944 ·Status: COMPLETED
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
NCT03802344 ·Status: COMPLETED ·Phase: PHASE3
-
A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream
NCT03462927 ·Status: COMPLETED ·Phase: PHASE2
-
Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis
NCT00141921 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept (Enbrel®) in Psoriasis - Pediatrics
NCT00078819 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis
NCT05078567 ·Status: UNKNOWN ·Phase: NA
-
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
NCT07340216 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Patients With Mild to Moderate Psoriasis
NCT01451346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Topical Calcitriol in Children With Psoriasis
NCT00006275 ·Status: COMPLETED ·Phase: NA
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
NCT00417820 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
NCT03987763 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
NCT03062618 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Clinical Study of KHK4827
NCT01782924 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Analysis of Pediatric Psoriasis
NCT03768284 ·Status: COMPLETED
-
Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
NCT00563524 ·Status: COMPLETED ·Phase: PHASE1